Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5546586 | Acta Pharmaceutica Sinica B | 2017 | 11 Pages |
Abstract
AMP-activated protein kinase (AMPK) has been identified as an attractive therapeutic target for cancer, type 2 diabetes, atherosclerosis, myocardial ischemia/reperfusion injury and neurodegenerative disease. This review summarizes and updates the paradoxical role of AMPK implicated in these human diseases and put forward the challenge encountered.326
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Drug Discovery
Authors
Jin Li, Liping Zhong, Fengzhong Wang, Haibo Zhu,